Clinical Trial Update: Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel-carboplatin-bevacizumab with or without nitroglycerin in metastatic non-squamous non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)
• paclitaxel-carboplatin-bevacizumab

Snippet

Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED